The Role of RWD in Revolutionizing Clinical Trial Design
Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people.
presented by
presented by
SDOH in Oncology: Mapping Out How Zip Code Can Affect Care Is a Critical Step to Improving Outcomes
For non small cell lung cancer patients, a zip code can mean the difference between diagnosis time and treatment options.
presented by
Using RWD, SDoH and Patient Mapping to Eliminate Blind Spots from the Patient Journey
This article is part of a series on eliminating blind spots in the patient journey by leveraging real-world data.
presented by
How Can RWD Transform the Patient Journey?
A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access.
presented by
Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies
The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer.
presented by
The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights
PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies.